Skip to content

The effect of rose oil essence on the sexual dysfunction of menopaused women

The effect of rose oil essence on the sexual dysfunction of menopaused women

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190818044553N1
Enrollment
90
Registered
2020-07-22
Start date
2020-08-22
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sexual Dysfunction. Sexual dysfunction, not caused by organic disorder or disease

Interventions

Intervention 1: Intervention group: Intervention group: Soft capsules containing 15 mg of essential oil (standardized based on the presence of at least 7.5 mg of citronellol in each soft capsule) base

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
45 Years to 65 Years

Inclusion criteria

Inclusion criteria: Women with normal menopause, Being between 45 and 65 years old, married, at least one year old and up to 5 since menopause Do not use any medication that affects a person's sexual response, including hormonal, herbal or complementary medications to relieve menopausal symptoms. No known mental health problems or systemic illness affecting sexual function Do not take any sedatives or antidepressants, aspirin or anticoagulants Lack of sensitivity to herbal medicines Absence of digestive disorders such as nausea, vomiting, nausea and vomiting No addiction or smoking having a minimum literacy in order to complete the questionnaire No accidents at least in the last 6 months

Exclusion criteria

Exclusion criteria: Creating any sensitivity to the essential oils used in this research Occurrence of any disease during this study that interferes with the results of this study. Reluctance to continue participating in research Do not take medication or placebo for more than 6 days during the study Use of other treatment and intervention methods to reduce menopausal symptoms during research other than the instructions provided by the researcher Occurrence of traumatic events such as loss of spouse or close relatives during the research period

Design outcomes

Primary

MeasureTime frame
Sexual function. Timepoint: before and 4 weeks after intervention, 8 weeks after intervention. Method of measurement: Female Sexual Function Index Questionnaire.;Quality of Life. Timepoint: Before and 4 weeks after intervention, 8 weeks after intervention. Method of measurement: Menopause Quality Of Life Questionnaire ( MENQOL).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRana Dousti

Tabriz University of Medical Sciences

rana.doosty2@gmail.com98 41365706391

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026